Thus, the nature of the chemotherapy treatment (which he referred to as the ‘partner’ or ‘backbone’ treatment) is both highly significant and complex and emphasizes the need to select the chemotherapy partner carefully, based on appropriate mechanism-based studies.
← all excerpts
Lessons from the first ecancer symposium on angiogenesis in gastric cancer.
1
—
—